140 related articles for article (PubMed ID: 31114333)
1. High miR-454-3p expression predicts poor prognosis in hepatocellular carcinoma.
Li Y; Jiao Y; Fu Z; Luo Z; Su J; Li Y
Cancer Manag Res; 2019; 11():2795-2802. PubMed ID: 31114333
[No Abstract] [Full Text] [Related]
2. Down-regulation of miR-342-3p in hepatocellular carcinoma tissues and its prognostic significance.
Gao Y; Zhang SG; Wang ZH; Liao JC
Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2098-2102. PubMed ID: 28537676
[TBL] [Abstract][Full Text] [Related]
3. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
Chen L; Chu F; Cao Y; Shao J; Wang F
Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of miR-655-3p predicts worse clinical outcome in patients suffering from hepatocellular carcinoma.
Zhao XQ; Liang B; Jiang K; Zhang HY
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):748-752. PubMed ID: 28272708
[TBL] [Abstract][Full Text] [Related]
5. Downregulated miR-23b-3p expression acts as a predictor of hepatocellular carcinoma progression: A study based on public data and RT-qPCR verification.
He RQ; Wu PR; Xiang XL; Yang X; Liang HW; Qiu XH; Yang LH; Peng ZG; Chen G
Int J Mol Med; 2018 May; 41(5):2813-2831. PubMed ID: 29484429
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of strand-specific miRNA-101-3p and miRNA-101-5p for hepatocellular carcinoma and a bioinformatic analysis of their possible mechanism of action.
Yang X; Pang YY; He RQ; Lin P; Cen JM; Yang H; Ma J; Chen G
FEBS Open Bio; 2018 Jan; 8(1):64-84. PubMed ID: 29321958
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma.
Liang HW; Ye ZH; Yin SY; Mo WJ; Wang HL; Zhao JC; Liang GM; Feng ZB; Chen G; Luo DZ
Onco Targets Ther; 2017; 10():3405-3419. PubMed ID: 28744145
[TBL] [Abstract][Full Text] [Related]
8. High miR-139-3p expression predicts a better prognosis for hepatocellular carcinoma: a pooled analysis.
Zhu Y; Zhou C; He Q
J Int Med Res; 2019 Jan; 47(1):383-390. PubMed ID: 30394818
[TBL] [Abstract][Full Text] [Related]
9. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles.
Wang X; Gao J; Zhou B; Xie J; Zhou G; Chen Y
Life Sci; 2019 Sep; 232():116596. PubMed ID: 31233760
[TBL] [Abstract][Full Text] [Related]
10. Identification of miR-101-3p targets and functional features based on bioinformatics, meta-analysis and experimental verification in hepatocellular carcinoma.
Li CY; Pang YY; Yang H; Li J; Lu HX; Wang HL; Mo WJ; Huang LS; Feng ZB; Chen G
Am J Transl Res; 2017; 9(5):2088-2105. PubMed ID: 28559963
[TBL] [Abstract][Full Text] [Related]
11. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression.
Xiao CZ; Wei W; Guo ZX; Zhang MY; Zhang YF; Wang JH; Shi M; Wang HY; Guo RP
J Cancer Res Clin Oncol; 2017 Feb; 143(2):263-273. PubMed ID: 27704267
[TBL] [Abstract][Full Text] [Related]
13. Role of microRNA-141-3p in the progression and metastasis of hepatocellular carcinoma cell.
Hou X; Yang L; Jiang X; Liu Z; Li X; Xie S; Li G; Liu J
Int J Biol Macromol; 2019 May; 128():331-339. PubMed ID: 30695725
[TBL] [Abstract][Full Text] [Related]
14. Investigation of miR-490-3p Expression in Hepatocellular Carcinoma Based on Reverse Transcription-Polymerase Chain Reaction (RT-qPCR) and a Meta-Analysis of 749 Cases.
Li MF; Zeng JJ; Pan AP; Lin YH; Lin HS; Zhang RZ; Yang L; Zhang Y; Dang YW; Chen G
Med Sci Monit; 2018 Jul; 24():4914-4925. PubMed ID: 30007991
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of PARPBP Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma.
Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
Dig Dis Sci; 2019 Oct; 64(10):2878-2892. PubMed ID: 30949905
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T
Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620
[TBL] [Abstract][Full Text] [Related]
17. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.
Chen S; Wang L; Yao B; Liu Q; Guo C
Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165
[TBL] [Abstract][Full Text] [Related]
18. CircSLC3A2 functions as an oncogenic factor in hepatocellular carcinoma by sponging miR-490-3p and regulating PPM1F expression.
Wang H; Chen W; Jin M; Hou L; Chen X; Zhang R; Zhang J; Zhu J
Mol Cancer; 2018 Nov; 17(1):165. PubMed ID: 30470261
[TBL] [Abstract][Full Text] [Related]
19. Significantly different expression levels of microRNAs associated with vascular invasion in hepatocellular carcinoma and their prognostic significance after surgical resection.
Song SK; Jung WY; Park SK; Chung CW; Park Y
PLoS One; 2019; 14(9):e0216847. PubMed ID: 31513595
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]